These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 26283746)
1. Potential Impact of Seasonal Malaria Chemoprevention on the Acquisition of Antibodies Against Glutamate-Rich Protein and Apical Membrane Antigen 1 in Children Living in Southern Senegal. Ndiaye M; Sylla K; Sow D; Tine R; Faye B; Ndiaye JL; Dieng Y; Lo AC; Abiola A; Cisse B; Ndiaye D; Theisen M; Gaye O; Alifrangis M Am J Trop Med Hyg; 2015 Oct; 93(4):798-800. PubMed ID: 26283746 [TBL] [Abstract][Full Text] [Related]
2. Evidence that seasonal malaria chemoprevention with SPAQ influences blood and pre-erythrocytic stage antibody responses of Plasmodium falciparum infections in Niger. Mahaman Moustapha L; Adamou R; Ibrahim ML; Abdoulaye Louis Padounou M; Diallo A; Courtin D; Testa J; Ndiaye JLA Malar J; 2021 Jan; 20(1):1. PubMed ID: 33386070 [TBL] [Abstract][Full Text] [Related]
3. Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali. Mahamar A; Issiaka D; Youssouf A; Niambele SM; Soumare HM; Attaher O; Barry A; Narum DL; Duffy PE; Greenwood B; Fried M; Dicko A Malar J; 2021 Jan; 20(1):23. PubMed ID: 33413417 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of molecular markers of drug resistance in an area of seasonal malaria chemoprevention in children in Senegal. Lo AC; Faye B; Ba el-H; Cisse B; Tine R; Abiola A; Ndiaye M; Ndiaye JL; Ndiaye D; Sokhna C; Gomis JF; Dieng Y; Faye O; Ndir O; Milligan P; Cairns M; Hallett R; Sutherland C; Gaye O Malar J; 2013 Apr; 12():137. PubMed ID: 23617576 [TBL] [Abstract][Full Text] [Related]
5. The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of Mozambique. Hogh B; Thompson R; Lobo V; Dgedge M; Dziegiel M; Borre M; Gottschau A; Streat E; Schapira A; Barreto J Acta Trop; 1994 Sep; 57(4):265-77. PubMed ID: 7810383 [TBL] [Abstract][Full Text] [Related]
6. High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1. Thomas AW; Trape JF; Rogier C; Goncalves A; Rosario VE; Narum DL Am J Trop Med Hyg; 1994 Dec; 51(6):730-40. PubMed ID: 7810805 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial. Cissé B; Ba EH; Sokhna C; NDiaye JL; Gomis JF; Dial Y; Pitt C; NDiaye M; Cairns M; Faye E; NDiaye M; Lo A; Tine R; Faye S; Faye B; Sy O; Konate L; Kouevijdin E; Flach C; Faye O; Trape JF; Sutherland C; Fall FB; Thior PM; Faye OK; Greenwood B; Gaye O; Milligan P PLoS Med; 2016 Nov; 13(11):e1002175. PubMed ID: 27875528 [TBL] [Abstract][Full Text] [Related]
8. IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamine. Quelhas D; Jiménez A; Quintó L; Serra-Casas E; Mayor A; Cisteró P; Puyol L; Wilson DW; Richards JS; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Aponte JJ; Alonso PL; Beeson JG; Menéndez C; Dobaño C Immunobiology; 2011 Jul; 216(7):793-802. PubMed ID: 21257227 [TBL] [Abstract][Full Text] [Related]
9. Antibody Correlates of Protection from Clinical Hamre KES; Ondigo BN; Hodges JS; Dutta S; Theisen M; Ayodo G; John CC Am J Trop Med Hyg; 2020 Dec; 103(6):2174-2182. PubMed ID: 33124533 [TBL] [Abstract][Full Text] [Related]
10. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana. Amoah LE; Nuvor SV; Obboh EK; Acquah FK; Asare K; Singh SK; Boampong JN; Theisen M; Williamson KC Parasit Vectors; 2017 Aug; 10(1):395. PubMed ID: 28835262 [TBL] [Abstract][Full Text] [Related]
11. Impact of age of first exposure to Plasmodium falciparum on antibody responses to malaria in children: a randomized, controlled trial in Mozambique. Nhabomba AJ; Guinovart C; Jiménez A; Manaca MN; Quintó L; Cisteró P; Aguilar R; Barbosa A; Rodríguez MH; Bassat Q; Aponte JJ; Mayor A; Chitnis CE; Alonso PL; Dobaño C Malar J; 2014 Mar; 13():121. PubMed ID: 24674654 [TBL] [Abstract][Full Text] [Related]
12. Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali. Mahamar A; Issiaka D; Barry A; Attaher O; Dembele AB; Traore T; Sissoko A; Keita S; Diarra BS; Narum DL; Duffy PE; Dicko A; Fried M Malar J; 2017 Jul; 16(1):289. PubMed ID: 28720100 [TBL] [Abstract][Full Text] [Related]
13. Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal. Oeuvray C; Theisen M; Rogier C; Trape JF; Jepsen S; Druilhe P Infect Immun; 2000 May; 68(5):2617-20. PubMed ID: 10768952 [TBL] [Abstract][Full Text] [Related]
14. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria. Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203 [TBL] [Abstract][Full Text] [Related]
15. Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum. Enevold A; Nkya WM; Theisen M; Vestergaard LS; Jensen AT; Staalsoe T; Theander TG; Bygbjerg IC; Alifrangis M Malar J; 2007 Nov; 6():153. PubMed ID: 18021388 [TBL] [Abstract][Full Text] [Related]
16. Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso. Cherif MK; Ouédraogo O; Sanou GS; Diarra A; Ouédraogo A; Tiono A; Cavanagh DR; Michael T; Konaté AT; Watson NL; Sanza M; Dube TJT; Sirima SB; Nebié I BMC Res Notes; 2017 Sep; 10(1):472. PubMed ID: 28886727 [TBL] [Abstract][Full Text] [Related]
17. Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial. NDiaye JL; Cissé B; Ba EH; Gomis JF; Ndour CT; Molez JF; Fall FB; Sokhna C; Faye B; Kouevijdin E; Niane FK; Cairns M; Trape JF; Rogier C; Gaye O; Greenwood BM; Milligan PJ PLoS One; 2016; 11(10):e0162563. PubMed ID: 27764102 [TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran. Rouhani M; Zakeri S; Mehrizi AA; Djadid ND Malar J; 2015 Feb; 14():58. PubMed ID: 25652589 [TBL] [Abstract][Full Text] [Related]
19. Antibody responses to P. falciparum Apical Membrane Antigen 1(AMA-1) in relation to haemoglobin S (HbS), HbC, G6PD and ABO blood groups among Fulani and Masaleit living in Western Sudan. Nasr A; Saleh AM; Eltoum M; Abushouk A; Hamza A; Aljada A; El-Toum ME; Abu-Zeid YA; Allam G; ElGhazali G Acta Trop; 2018 Jun; 182():115-123. PubMed ID: 29486174 [TBL] [Abstract][Full Text] [Related]
20. Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria? Nebie I; Tiono AB; Diallo DA; Samandoulougou S; Diarra A; Konate AT; Cuzin-Ouattara N; Theisen M; Corradin G; Cousens S; Ouattara AS; Ilboudo-Sanogo E; Sirima BS Trop Med Int Health; 2008 Feb; 13(2):229-37. PubMed ID: 18304269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]